These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9368911)

  • 1. Pirlindole: a selective reversible inhibitor of monoamine oxidase A. A review of its preclinical properties.
    Bruhwyler J; Liégeois JF; Géczy J
    Pharmacol Res; 1997 Jul; 36(1):23-33. PubMed ID: 9368911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of 2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino [3,2,1-j,k]carbazol hydrochloride (pirlindole), a new antidepressant.
    Mashkovsky MD; Andrejeva NI
    Arzneimittelforschung; 1981; 31(1):75-9. PubMed ID: 7194096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase-A and on GABAA receptors.
    Medvedev AE; Shvedov VI; Chulkova TM; Fedotova OA; Saederup E; Squires RF
    Neurochem Res; 1996 Dec; 21(12):1521-6. PubMed ID: 8953568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirlindole in the treatment of depression and fibromyalgia syndrome.
    Branco JC; Tomé AM; Cruz MR; Filipe A
    Clin Drug Investig; 2011 Oct; 31(10):675-89. PubMed ID: 21877764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABAA receptor binding.
    Medvedev AE; Shvedov VI; Chulkova TM; Fedotova OA; Saederup E; Squires RF
    J Neural Transm Suppl; 1998; 52():337-42. PubMed ID: 9564636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of brain monoamine oxidase in the rat by multiple pyrazidol administration].
    Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
    Biull Eksp Biol Med; 1985 May; 99(5):583-4. PubMed ID: 4005414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The new antidepressant tetrindole].
    Mashkovskiĭ MD; Glushkov RG; Shvedov VI; Andreeva NI; Golovina SM
    Eksp Klin Farmakol; 1993; 56(2):3-6. PubMed ID: 8348033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of pirlindole, a selective RIMA, and its two enantiomers using biochemical and behavioural techniques.
    Bruhwyler J; Liégeois JF; Gérardy J; Damas J; Chleide E; Lejeune C; Decamp E; de Tullio P; Delarge J; Dresse A; Géczy J
    Behav Pharmacol; 1998 Dec; 9(8):731-7. PubMed ID: 9890262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR analysis.
    Medvedev AE; Ramsay RR; Ivanov AS; Veselovsky AV; Shvedov VI; Tikhonova OV; Barradas AP; Davidson CK; Moskvitina TA; Fedotova OA; Axenova LN
    Neurobiology (Bp); 1999; 7(2):151-8. PubMed ID: 10591049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and post-treatment with pirlindole and dehydropirlindole protects cultured brain cells against nitric oxide-induced death.
    Boland A; Gérardy J; Mossay D; Seutin V
    Eur J Pharmacol; 2003 Apr; 466(1-2):21-30. PubMed ID: 12679138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of pirlindole, a new tetracyclic antidepressant agent.
    Fiedler VB; Buchheim S; Nitz RE; Scholtholt J
    Arzneimittelforschung; 1983; 33(2):244-50. PubMed ID: 6682664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake.
    Ortmann R; Radeke E; Buech O; Sigg K; Rogg H; Glatt A; Truog A; Jaekel J; Everitt BJ; Delini-Stula A
    Arzneimittelforschung; 1986 Dec; 36(12):1727-32. PubMed ID: 3566833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G; Finberg JP; Youdim MB
    Clin Neuropharmacol; 1993; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.